BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33257573)

  • 1. Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1) rescues the cellular phenotype of MELAS by inducing homeostatic mechanisms.
    Aras S; Purandare N; Gladyck S; Somayajulu-Nitu M; Zhang K; Wallace DC; Grossman LI
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32056-32065. PubMed ID: 33257573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.
    Purandare N; Somayajulu M; Hüttemann M; Grossman LI; Aras S
    J Biol Chem; 2018 Apr; 293(17):6517-6529. PubMed ID: 29540477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abl2 kinase phosphorylates Bi-organellar regulator MNRR1 in mitochondria, stimulating respiration.
    Aras S; Arrabi H; Purandare N; Hüttemann M; Kamholz J; Züchner S; Grossman LI
    Biochim Biophys Acta Mol Cell Res; 2017 Feb; 1864(2):440-448. PubMed ID: 27913209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.
    Bhattacharya S; Yin J; Huo W; Chaum E
    Stem Cell Res Ther; 2022 Jun; 13(1):260. PubMed ID: 35715869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease.
    Gao X; Jiang Z; Yan X; Liu J; Li F; Liu P; Li J; Wei Y; Sun YE; Zhang Y; Wang C
    Cell Death Dis; 2021 Jul; 12(7):701. PubMed ID: 34262025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism.
    Aras S; Bai M; Lee I; Springett R; Hüttemann M; Grossman LI
    Mitochondrion; 2015 Jan; 20():43-51. PubMed ID: 25315652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MELAS mutation m.3243A>G alters the expression of mitochondrial tRNA fragments.
    Meseguer S; Navarro-González C; Panadero J; Villarroya M; Boutoual R; Sánchez-Alcázar JA; Armengod ME
    Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1433-1449. PubMed ID: 31195049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells.
    Burgin HJ; Lopez Sanchez MIG; Smith CM; Trounce IA; McKenzie M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial autoimmunity and MNRR1 in breast carcinogenesis.
    Aras S; Maroun MC; Song Y; Bandyopadhyay S; Stark A; Yang ZQ; Long MP; Grossman LI; Fernández-Madrid F
    BMC Cancer; 2019 May; 19(1):411. PubMed ID: 31046734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts.
    Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA
    FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical chorioamnionitis at term is characterized by changes in the plasma concentration of CHCHD2/MNRR1, a mitochondrial protein.
    Bosco M; Romero R; Gallo DM; Suksai M; Gotsch F; Jung E; Chaemsaithong P; Tarca AL; Gomez-Lopez N; Arenas-Hernandez M; Meyyazhagan A; Al Qasem M; Franchi MP; Grossman LI; Aras S; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2222333. PubMed ID: 37349086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the participation of CHCHD2/MNRR1, a mitochondrial protein, in spontaneous labor at term and in preterm labor with intra-amniotic infection.
    Bosco M; Romero R; Gallo DM; Suksai M; Gotsch F; Jung E; Chaemsaithong P; Tarca AL; Gomez-Lopez N; Arenas-Hernandez M; Meyyazhagan A; Al Qasem M; Franchi MP; Grossman LI; Aras S; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183088. PubMed ID: 36941246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.
    Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I
    Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Transfer of Wharton's Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts.
    Lin TK; Chen SD; Chuang YC; Lan MY; Chuang JH; Wang PW; Hsu TY; Wang FS; Tsai MH; Huang ST; Wang XW; Tsai PC; Lin HY; Liou CW
    Oxid Med Cell Longev; 2019; 2019():9537504. PubMed ID: 31249652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
    Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.
    Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.
    Matthews PM; Brown RM; Morten K; Marchington D; Poulton J; Brown G
    Hum Genet; 1995 Sep; 96(3):261-8. PubMed ID: 7649539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.